Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Bipolar Disorder Clinical Trials

101 recruiting trials for Bipolar Disorder. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
101
Total Trials
101
Recruiting Now
4
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT05669703

NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder

Background: Mood disorders, such as bipolar disorder, can have serious effects on a person s life. People with bipolar disorder are more likely to have heart disease and abuse...

Sponsor: National Institute of Mental Health (NIMH)Enrolling: 12601 location
RECRUITINGNCT06182787

Development of a Model for Digital Monitoring of the Mental State of the Hospitalized Patient

This study presents the development and validation of a unique Digital Experience Sampling Method (ESM) questionnaire specifically adapted for monitoring changes in the mental...

Sponsor: Sheba Medical CenterEnrolling: 1301 location
RECRUITINGNCT06363981

Multisite rTMS for Mood, Cognitive Impairment and Other Symptoms of Depression

Depressed mood is the main symptom of depression, but other symptoms like cognitive impairment, anhedonia or sleep disorders may also contribute to patients suffering and are...

Sponsor: Jakub AntczakEnrolling: 901 location
RECRUITINGPhase 4NCT05648591

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

To evaluate the safety and tolerability of iloperidone in adolescent patients with schizophrenia or bipolar I disorder for up to 52 weeks of treatment.

Sponsor: Vanda PharmaceuticalsEnrolling: 1009 locations
RECRUITINGEarly Phase 1NCT03748446

Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder

The investigators will test the hypothesis that inhaled xenon will produce a rapid improvement in depressive symptoms in patients suffering from treatment-resistant depression....

Sponsor: Massachusetts General HospitalEnrolling: 201 location
RECRUITINGNCT07020364

Feasibility and Safety of a Single Working Element for Bipolar and Laser Enucleation in Prostate Surgery: A Prospective...

A prospective feasibility study would be a practical first step, focusing on real-time assessment and ensuring the new working element's integration is safe and effective before...

Sponsor: Menoufia UniversityEnrolling: 601 location
RECRUITINGNCT04815239

Early Intervention for Youth at High Risk for Bipolar Disorder

Investigators will conduct a confirmatory efficacy trial of Interpersonal and Social Rhythm Therapy (IPSRT) delivered via telehealth for offspring of bipolar parents (OBP; age...

Sponsor: University of PittsburghEnrolling: 1201 location
RECRUITINGNCT06729541

Development and Application of Precision Treatment Strategies for Common Mental Disorders

Schizophrenia (SCH), major depressive disorder (MDD), and bipolar disorder (BPD) are prevalent, disabling psychiatric conditions that not only cause significant suffering for...

Sponsor: Peking UniversityEnrolling: 6001 location
RECRUITINGNCT06071858

Enhanced Coordinated Specialty Care for Early Psychosis

The goal of this clinical trial is to compare engagement in treatment in coordinated specialty care (CSC) to five extra care elements (CSC 2.0) in first-episode psychosis. The...

Sponsor: Mclean HospitalEnrolling: 3505 locations
RECRUITINGNCT06929533

Pharmacogenomics-Supported Psychotropic Prescribing Trial

Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in Manitoba.

Sponsor: University of ManitobaEnrolling: 2002 locations
RECRUITINGNCT07082777

Recovery in Telling Life Stories

This project tests the Recovery In Telling Life Stories (RETELL) intervention, aimed at supporting personal recovery in people with severe mental illness (SMI). While many of...

Sponsor: University of AarhusEnrolling: 201 location
RECRUITINGNCT05153382

Dialectical Behavior Therapy for Youth With and/or at Familial Risk for Bipolar Disorder

Dialectical behavior therapy (DBT) will be conducted over 1 year in youth with and/or at familial risk for bipolar disorder (BD). DBT will be divided into two modalities: 1) DBT...

Sponsor: Centre for Addiction and Mental HealthEnrolling: 601 location
RECRUITINGPhase 4NCT05913947

Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)

The goal is to study the effect of lithium compared to cariprazine in patients with depression in a bipolar disease. The main question it aims to answer is: Difference in change...

Sponsor: Aalborg University HospitalEnrolling: 1221 location
RECRUITINGNCT06508450

A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults

Researchers aim to test a brief culturally-responsive young adult orientation program for community mental health services. They will conduct a 24-month randomized trial with 80...

Sponsor: New York UniversityEnrolling: 801 location
RECRUITINGNCT06983834

Mindfulness Psychoeducation for Bipolar Disorder Caregivers' Mindfulness, Burden, Quality of Life and Resilience

This study was designed to determine the effect of mindfulness-based psychoeducation applied to primary caregivers of individuals diagnosed with bipolar disorder on their...

Sponsor: Pamukkale UniversityEnrolling: 461 location
RECRUITINGNCT05427123

Children's Bipolar Network Treatment Trial I

This is a naturalistic treatment and follow-up study of youth with bipolar spectrum disorders (BSDs) across four US sites of The Childhood Bipolar Network (CBN). CBN sites have...

Sponsor: University of California, Los AngelesEnrolling: 804 locations
RECRUITINGNCT05866107

App and Body Fat Scale in the Management of Overweight Patients

This study tests whether using a health app (Huawei Health) and a smart body fat scale can help overweight patients with schizophrenia or bipolar disorder lose weight and stay...

Sponsor: Capital Medical UniversityEnrolling: 2041 location
RECRUITINGPhase 1NCT05025605

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

This is a study of the efficacy and safety of BXCL501 in children and adolescents with acute agitation and either bipolar disorder or schizophrenia.

Sponsor: BioXcel Therapeutics IncEnrolling: 1405 locations
RECRUITINGNCT06897670

Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared...

The purpose of this research is to measure brain activity in individuals with mood disorders and memory problems using a simple, safe, and noninvasive method called functional...

Sponsor: Mayo ClinicEnrolling: 2001 location
RECRUITINGNCT07121894

Ketogenic Intervention for Bipolar Depression

The purpose of this study is to assess the clinical correlates of therapeutic precision ketosis in bipolar depression and to evaluate the cardiometabolic correlates associated...

Sponsor: Mayo ClinicEnrolling: 301 location
RECRUITINGNCT04184375

Cognitive Stimulation for Elderly Bipolar Patients

Age is a major risk factor for the development of cognitive disorders and neurodegenerative pathologies. Cognitive disorders during the phases of bipolar disease are known to...

Sponsor: Groupe Hospitalier de la Rochelle Ré AunisEnrolling: 401 location
RECRUITINGNCT06555406

Healthy Lifestyles in Bipolar Disorder: Bay Area Study

The goal of this clinical trial is to understand how level of adherence with time-restricted eating (TRE) predicts change in diurnal rhythms (as measured using the amplitude of...

Sponsor: University of California, BerkeleyEnrolling: 1501 location
RECRUITINGNCT06134349

The Bipolar Lithium Imaging Scan Study.

The main goal of this study is to determine if brain lithium-concentrations predict clinical lithium treatment-response. Secondary, to study correlations between intracerebral...

Sponsor: Leiden University Medical CenterEnrolling: 801 location
RECRUITINGNCT07246044

HD-tDCS for Adolescent Bipolar Depression Targeting S1

This randomized, double-blind, sham-controlled clinical trial aims to evaluate the efficacy and underlying biological mechanisms of HD-tDCS targeting the primary somatosensory...

Sponsor: Jiangsu Province Nanjing Brain HospitalEnrolling: 1001 location
RECRUITINGNCT06687694

Immune Mechanisms of Antipsychotic Treatment Response

The aim of this study is to investigate the role of the immune system in psychotic symptoms and their response to treatment. The investigators will collect blood and cerebrospinal...

Sponsor: King's College LondonEnrolling: 5001 location
RECRUITINGPhase 2NCT05296356

OSU6162 in Bipolar Depression (OBID)

An explorative, open label, single armed, flexible dose, single center, phase IIa study of 8 weeks, initiated in subjects with bipolar depression. The study will consist of 9...

Sponsor: Göteborg UniversityEnrolling: 221 location
RECRUITINGNCT06740331

Social Cognition, Memory, and Executive Functions in Bipolar Disorder and Major Depressive Disorder

Bipolar disorder (BD) are common psychiatric disorders often misdiagnosed, leading to delayed treatment. Even during stable phases, individuals with bipolar disorder experience...

Sponsor: CHU de ReimsEnrolling: 1801 location
RECRUITINGNCT05409794

Basal Plasma Lithium Levels and Suicidal Events

Suicidal behavior is a major public health issue and there are currently no specific treatments for it. However, lithium, the reference treatment for bipolar disorder, have been...

Sponsor: University Hospital, MontpellierEnrolling: 1581 location
RECRUITINGPhase 1NCT06305598

Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration...

This phase I trial tests the change in androgen receptor sensitivity, side effects and effectiveness of bipolar androgen therapy, using testosterone, in patients with castration...

Sponsor: Roswell Park Cancer InstituteEnrolling: 141 location
RECRUITINGNCT06914284

Apathy-related Neurobehavioral Markers of Cognitive Decline in Old-age Bipolar Disorders: Proof-of-concept

The goal of this clinical trial is to identify reliable markers of apathy in elderly subjects with bipolar disorder, age between 70 and 85 years, in order to accurately identify...

Sponsor: Hospital Center Guillaume RégnierEnrolling: 301 location
RECRUITINGNCT06978452

Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health Trajectories

Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health (BLOOM) is a project that aims to overcome age and diagnostic boundaries to generate...

Sponsor: Douglas Mental Health University InstituteEnrolling: 5601 location
RECRUITINGNCT03217110

Cerebellar Stimulation and Cognitive Control

The purpose of this study is to examine whether cerebellar stimulation can be used to improve cognitive deficits and mood in patients with schizophrenia, autism, bipolar disorder,...

Sponsor: Krystal Parker, PhDEnrolling: 2001 location
RECRUITINGNCT05934474

Biocollection on Peripheral Inflammation

Most psychiatric research is based on the nosographic classifications used in current practice. At present, there is no diagnostic or prognostic biomarker for psychiatric...

Sponsor: Nantes University HospitalEnrolling: 3001 location
RECRUITINGNCT06706687

A Study of the Behavioral Variant of Frontotemporal Dementia and Bipolar Disorder: a Neuroimaging and Epigenetics...

The aim of this study is to investigate the selective epigenetic modifications and their effect on brain's morphology and functionality in the frontotemporal dementia behavioral...

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoEnrolling: 2101 location
RECRUITINGNCT07211750

Integrated Care for Older Adults With Major Depression and Physical Multimorbidity - The I-CONNECT

The goal of this clinical trial is to learn if I-CONNECT (Integrated Care for Older Adults with Major Depression and Physical Multimorbidity) can improve the health and well-being...

Sponsor: KU LeuvenEnrolling: 821 location
RECRUITINGPhase 3NCT07140913

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed...

The purpose of this study is to evaluate the efficacy and safety of adjunctive KarXT for the treatment of mania in participants with Bipolar-I Disorder.

Sponsor: Bristol-Myers SquibbEnrolling: 42420 locations
RECRUITINGNCT04946916

Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease

The validation of biomarkers allowing the discrimination of cognitive and behavioral disorders of psychiatric origin from those of neurodegenerative origin would facilitate...

Sponsor: Hôpital le VinatierEnrolling: 1202 locations
RECRUITINGNCT07359157

Changing Lives and Changing Outcomes-9 at Worcester Recovery Center and Hospital

People with serious mental illness (depression, bipolar, and schizophrenia spectrum disorders) have high rates of repeated criminal legal involvement and psychiatric...

Sponsor: Massachusetts General HospitalEnrolling: 401 location
RECRUITINGNCT05945277

Critical Time Intervention-Peer Support

There is increasing awareness of the importance of providing mental health services and support that promote a recovery-oriented and human rights-based approach. A mental health...

Sponsor: Lisbon Institute of Global Mental Health - LIGMHEnrolling: 603 locations
RECRUITINGNCT06274567

Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder

The objective of this study protocol is to test whether intermittent theta-burst transcranial magnetic stimulation (iTBS-TMS) to the inferior parietal lobule (IPL) can strengthen...

Sponsor: Massachusetts General HospitalEnrolling: 1362 locations
RECRUITINGNCT05699525

Personalized Mobile Cognitive Behavioral Therapy Application

This study aims to compare the effectiveness of a standard mobile iPhone cognitive behavioral therapy program to a personalized mobile iPhone cognitive behavioral therapy program...

Sponsor: Weill Medical College of Cornell UniversityEnrolling: 1001 location
RECRUITINGNCT07306468

Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life

This observational study aims to evaluate exercise capacity, pulmonary function, respiratory muscle strength, and quality of life in individuals diagnosed with schizophrenia and...

Sponsor: Çankırı Karatekin UniversityEnrolling: 1501 location
RECRUITINGPhase 4NCT04580134

CLOZAPINE Response in Biotype-1

The CLOZAPINE study is designed as a multisite study across 5 sites and is a clinical trial, involving human participants who are prospectively assigned to an intervention. The...

Sponsor: University of Texas Southwestern Medical CenterEnrolling: 5245 locations
RECRUITINGNCT06313918

Exercise Therapy in Mental Disorders-study

The study will compare standard high-intensity training with brief high-intensity training in people with schizophrenia-spectrum or bipolar disorder. The overall aim is to...

Sponsor: Haukeland University HospitalEnrolling: 501 location
RECRUITINGNCT07108257

Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for the Treatment of Refractory Bipolar Depression

The goal of this clinical trial is to evaluate the safety and initial effectiveness of MR-guided focused ultrasound (MRgFUS) bilateral capsulotomy in patients with...

Sponsor: Sunnybrook Health Sciences CentreEnrolling: 101 location
RECRUITINGNCT06740383

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

The Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS) study aims to understand the early stages of psychotic disorders like Schizophrenia,...

Sponsor: Beth Israel Deaconess Medical CenterEnrolling: 3206 locations
RECRUITINGNCT06188754

Healthy Lifestyles for Bipolar Disorder

The goal of this clinical trial is to compare the effects of two different healthy lifestyles on outcomes for those with bipolar disorder. The goals are to understand the...

Sponsor: University of California, BerkeleyEnrolling: 3001 location
RECRUITINGNCT06408012

An Innovative Master Platform for Clinical Trials in Mood Disorders

Mood disorders such as depression and bipolar disorder affect over 350 million people around the world. While several effective treatments exist, it is often difficult to match...

Sponsor: St. Joseph's Healthcare HamiltonEnrolling: 9009 locations
RECRUITINGNCT06872398

Medical Comorbidities in Bipolar Disorder

Bipolar Disorder (BD) is a common, heritable, chronic, and recurrent disorder that represents a critical public health problem, due to its prevalence, its high degree of...

Sponsor: Fondation FondaMentalEnrolling: 801 location
RECRUITINGNCT06657430

A Study on the Preference of Risperidone Dosage Forms

This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.

Sponsor: Shanghai Mental Health CenterEnrolling: 10001 location

Showing 50 of 101 trials.Search all Bipolar Disorder trials

Frequently Asked Questions

There are currently 101 clinical trials for Bipolar Disorder, with 101 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Bipolar Disorder, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 4 Phase 3 trials for Bipolar Disorder, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.

The this entity record above pulls directly from the NIH ClinicalTrials.gov registry. What follows is the per-entity context — how this entity sits in the broader U.S. clinical trials and research registries distribution and which underlying factors drive the headline numbers.

Every number on this page links back to the NIH ClinicalTrials.gov registry; the methodology page describes the inputs, refresh cadence, and known limitations of the underlying data product.

For readers using this page as a decision input, the related-entity pages elsewhere on the site provide the comparison set. The most useful comparison for this entity is typically a peer within active and historical clinical trials with similar size, similar exposure, or similar geography — not the national-level summary alone.